drugset / Trial / NCT05814809
Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To evaluate the safety and the pharmacokinetics of the JP-1366 20 mg tablet and capsule oral administration in healthy adult volunteers.
Timeline
- Start
- 2022-09-30
- Primary completion
- 2022-10-09
- Completion
- 2022-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JP-1366 | Unknown | 20 mg | Oral |
Indications
No indication recorded.